Condition: Prostate Cancer · Sponsor: Weill Medical College of Cornell University
This study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (AS) with low risk and favorable intermediate-risk prostate cancer.
This description comes directly from the study's public registry record.
Holly Kuczynski · 646-962-7523 · hok4001@med.cornell.edu
Sarah Yuan · 646-962-6040 · say7008@med.cornell.edu
Always discuss trial participation with your own doctor first.
| UCLA | Los Angeles, California, United States | Not Yet Recruiting |
| UCSF | San Francisco, California, United States | Not Yet Recruiting |
| Weill Cornell Medicine - New York Presbyterian Hospital | New York, New York, United States | Recruiting |
| UH Cleveland Medical Center | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05948657